Carnegie Investment Counsel’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Sell |
|
|||||
|
2025
Q4 | $1.19M | Sell |
|
|||||
|
2025
Q3 | $1.07M | Hold |
|
|||||
|
2025
Q2 | $974K | Sell |
|
|||||
|
2025
Q1 | $1.13M | Buy |
|
|||||
|
2024
Q4 | $1.08M | Sell |
|
|||||
|
2024
Q3 | $1.35M | Buy |
|
|||||
|
2024
Q2 | $1.35M | Buy |
|
|||||
|
2024
Q1 | $1.16M | Sell |
|
|||||
|
2023
Q4 | $1.2M | Sell |
|
|||||
|
2023
Q3 | $1.21M | Sell |
|
|||||
|
2023
Q2 | $1.28M | Sell |
|
|||||
|
2023
Q1 | $1.24M | Buy |
|
|||||
|
2022
Q4 | $1.18M | Buy |
|
|||||
|
2022
Q3 | $941K | Buy |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $1.11M | Sell |
|
|||||
|
2021
Q4 | $1.04M | Buy |
|
|||||
|
2021
Q3 | $1.06M | Hold |
|
|||||
|
2021
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $201K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $244K | Buy |
|